These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 26401934

  • 1. Long-Term Interrelationship between Brain Metabolism and Amyloid Deposition in Mild Cognitive Impairment.
    Kemppainen N, Joutsa J, Johansson J, Scheinin NM, Någren K, Rokka J, Parkkola R, Rinne JO.
    J Alzheimers Dis; 2015; 48(1):123-33. PubMed ID: 26401934
    [Abstract] [Full Text] [Related]

  • 2. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    Iaccarino L, Chiotis K, Alongi P, Almkvist O, Wall A, Cerami C, Bettinardi V, Gianolli L, Nordberg A, Perani D.
    J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
    [Abstract] [Full Text] [Related]

  • 3. Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.
    Hatashita S, Wakebe D.
    J Alzheimers Dis; 2017; 57(3):765-773. PubMed ID: 28304292
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decreased hippocampal metabolism in high-amyloid mild cognitive impairment.
    Hanseeuw BJ, Schultz AP, Betensky RA, Sperling RA, Johnson KA.
    Alzheimers Dement; 2016 Dec; 12(12):1288-1296. PubMed ID: 27421609
    [Abstract] [Full Text] [Related]

  • 13. [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment.
    Brück A, Virta JR, Koivunen J, Koikkalainen J, Scheinin NM, Helenius H, Någren K, Helin S, Parkkola R, Viitanen M, Rinne JO.
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1567-72. PubMed ID: 23801168
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
    Bauckneht M, Chincarini A, Piva R, Arnaldi D, Girtler N, Massa F, Pardini M, Grazzini M, Efeturk H, Pagani M, Sambuceti G, Nobili F, Morbelli S.
    Alzheimers Res Ther; 2018 Apr 03; 10(1):35. PubMed ID: 29615111
    [Abstract] [Full Text] [Related]

  • 16. Comparison of Brain Amyloid Deposition and Cortical Glucose Metabolism Between Clinic- and Community-Based Cohort.
    Yabuuchi K, Kimura N, Masuda T, Matsubara E.
    J Alzheimers Dis; 2023 Apr 03; 95(1):299-306. PubMed ID: 37483008
    [Abstract] [Full Text] [Related]

  • 17. Association of Cerebrospinal Fluid Adiponectin Levels With Cerebral Glucose Metabolism In Mild Cognitive Impairment: A Pilot Study.
    Ataka T, Kimura N, Mizukami T, Uchida H, Matsubara E.
    Curr Alzheimer Res; 2020 Apr 03; 17(12):1126-1132. PubMed ID: 33167835
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cognitive decline and amyloid accumulation in patients with mild cognitive impairment.
    Koivunen J, Karrasch M, Scheinin NM, Aalto S, Vahlberg T, Någren K, Helin S, Viitanen M, Rinne JO.
    Dement Geriatr Cogn Disord; 2012 Apr 03; 34(1):31-7. PubMed ID: 22868352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.